Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade
Polovin's sale of 30,075 shares was non-discretionary and tied to tax withholding from RSU vesting.
Overview
Andrew Polovin, the firm's EVP and chief legal officer, sold 30,075 shares of Tempus AI, Inc. (NASDAQ:TEM) at $51.29 per share in a transaction totaling $1.5 million, according to an SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average sale price ($51.29); post-transaction value based on the August 19 market close ($61.25).
Details
Tempus AI is a healthcare technology company headquartered in Chicago, with a $10.7 billion market capitalization and 3,800 employees. The company has established a vertically integrated platform combining clinical software, diagnostic analytics, and laboratory services to address the precision medicine market, though it remains unprofitable on a TTM basis with negative net income of $254.4 million as it invests in platform expansion and market penetration.
Source
Originally published at www.fool.com.